Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

If you're not paying close attention, the first stage can be easy to miss. COPD treatment goal is to help you breathe easier and help regular activities. Medications along with lifestyle ...

COPD-asthma-devices-market2025 PORTLAND, DE, UNITED STATES, January 29, 2025 /EINPresswire / -- Day-to-day exposure to environmental pollutio ...

In a world where respiratory issues are increasingly common, finding practical solutions can be daunting. Breathe Drops ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $73.94 billion, finds itself at a critical juncture as it navigates challenges to its flagship Eylea franchise while ...

The Victorian Government is backing local medical technology startup Diag-Nose Medical to develop new treatments for chronic ...

GSK plc GSK recently announced that EMA has accepted the regulatory filing seeking approval for its IL-5 inhibitor ...

Regene Brantley-Reed claimed three Macon County deputies failed to protect her husband, John Reed, from violent felon Daniel Pollard III.

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

SAN FRANCISCO and BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Guggenheim ...

Data from the largest patient-reported real-world data exploration underlines new opportunities for medical research to ...

Independent investment company Breakthrough Victoria is investing $800,000 in Diag-Nose.io Medical (DNM), a Melbourne based ...